FDA Inspection 1243750 — Ermis MedTech GmbH
The FDA completed an inspection of Ermis MedTech GmbH on June 12, 2024 in Tuttlingen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 12, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Tuttlingen (Germany)